Schedules of Controlled Substances: Rescheduling FDA-Approved Cannabis Products
The FDA approved cannabis products rescheduling from Schedule I to Schedule III marks a significant regulatory update. This change eases prescribing and research barriers for clinicians. It also streamlines permit requirements, enhancing patient access…
New Study Captures Oklahoma Medical Marijuana Business Opinions for 2026
The 2026 Oklahoma medical marijuana business study aims to gather insights from industry owners and workers. This study highlights operational challenges and regulatory impacts on patient access. Understanding these factors is crucial for anticipating…
Proposed Nebraska Medical Marijuana Emergency Rules Spark Concern (THC Limits, Rural Access)
Nebraska medical cannabis rules propose a 5-gram THC limit every 90 days and a 40-milligram per-dose cap. These restrictions risk undertreating patients with serious conditions. Rural access issues further complicate patient care under these rules.
Legalizing Medical and Recreational Cannabis May Decrease Adolescent Use
The association cannabis use other substances lifestyle is crucial to understanding adolescent cannabis use trends. Recent studies show legalization may decrease adolescent use. This association informs better policies and health strategies.